Veracyte to Participate in Upcoming Investor Conferences
Veracyte (VCYT) has announced its participation in four major investor conferences in November. The cancer diagnostics company will conduct fireside chats at the UBS Healthcare Conference (November 12th, 2:45 PM ET), Guggenheim Inaugural Healthcare Innovation Conference (November 13th, 3:00 PM ET), Wolfe Research Healthcare Conference (November 19th, 1:40 PM ET), and Stephens Annual Investor Conference (November 20th, 4:00 PM ET). Live audio webcasts will be available on Veracyte's investor website, with replays accessible for 90 days after each presentation.
Veracyte (VCYT) ha annunciato la sua partecipazione a quattro importanti conferenze per investitori nel mese di novembre. La società di diagnosi per il cancro condurrà discussioni informali alla UBS Healthcare Conference (12 novembre, ore 14:45 ET), alla Guggenheim Inaugural Healthcare Innovation Conference (13 novembre, ore 15:00 ET), alla Wolfe Research Healthcare Conference (19 novembre, ore 13:40 ET), e alla Stephens Annual Investor Conference (20 novembre, ore 16:00 ET). Le trasmissioni audio in diretta saranno disponibili sul sito per investitori di Veracyte, con riproduzioni accessibili per 90 giorni dopo ogni presentazione.
Veracyte (VCYT) ha anunciado su participación en cuatro importantes conferencias de inversores en noviembre. La empresa de diagnóstico del cáncer llevará a cabo charlas informales en la UBS Healthcare Conference (12 de noviembre, 2:45 PM ET), en la Guggenheim Inaugural Healthcare Innovation Conference (13 de noviembre, 3:00 PM ET), en la Wolfe Research Healthcare Conference (19 de noviembre, 1:40 PM ET), y en la Stephens Annual Investor Conference (20 de noviembre, 4:00 PM ET). Las retransmisiones de audio en vivo estarán disponibles en el sitio web para inversores de Veracyte, con repeticiones accesibles durante 90 días después de cada presentación.
Veracyte (VCYT)는 11월에 열리는 네 개의 주요 투자자 회의에 참여한다고 발표했습니다. 이 암 진단 회사는 UBS Healthcare Conference (11월 12일, 오후 2:45 ET), Guggenheim Inaugural Healthcare Innovation Conference (11월 13일, 오후 3:00 ET), Wolfe Research Healthcare Conference (11월 19일, 오후 1:40 ET), 그리고 Stephens Annual Investor Conference (11월 20일, 오후 4:00 ET)에서 정보 교류를 진행할 예정입니다. Veracyte의 투자자 웹사이트에서 실시간 오디오 웹캐스트를 제공하며, 각 발표 후 90일 동안 재생할 수 있습니다.
Veracyte (VCYT) a annoncé sa participation à quatre grandes conférences d'investisseurs en novembre. La société de diagnostics du cancer animera des discussions informelles lors de la UBS Healthcare Conference (12 novembre, 14h45 ET), de la Guggenheim Inaugural Healthcare Innovation Conference (13 novembre, 15h00 ET), de la Wolfe Research Healthcare Conference (19 novembre, 13h40 ET), et de la Stephens Annual Investor Conference (20 novembre, 16h00 ET). Des webcasts audio en direct seront disponibles sur le site des investisseurs de Veracyte, avec des rediffusions accessibles pendant 90 jours après chaque présentation.
Veracyte (VCYT) hat die Teilnahme an vier wichtigen Investorenkonferenzen im November angekündigt. Das Unternehmen für Krebsdiagnose wird informelle Gespräche bei der UBS Healthcare Conference (12. November, 14:45 Uhr ET), der Guggenheim Inaugural Healthcare Innovation Conference (13. November, 15:00 Uhr ET), der Wolfe Research Healthcare Conference (19. November, 13:40 Uhr ET) und der Stephens Annual Investor Conference (20. November, 16:00 Uhr ET) führen. Live-Audio-Webcasts werden auf Veracytes Investorenwebsite verfügbar sein, mit Wiederholungen, die 90 Tage nach jeder Präsentation zugänglich sind.
- None.
- None.
-
UBS Healthcare Conference –
Rancho Palos Verdes, CA
Fireside Chat on November 12th at 2:45 p.m. Eastern Time
-
Guggenheim Inaugural Healthcare Innovation Conference –
Boston, MA
Fireside Chat on November 13th at 3:00 p.m. Eastern Time
-
Wolfe Research Healthcare Conference –
New York, NY
Fireside Chat on November 19th at 1:40 p.m. Eastern Time
-
Stephens Annual Investor Conference –
Nashville, TN
Fireside Chat on November 20th at 4:00 p.m. Eastern Time
Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. Replays of the webcasts will be available for 90 days after each live presentation broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter).
View source version on businesswire.com: https://www.businesswire.com/news/home/20241029391463/en/
Investors:
Shayla Gorman
investors@veracyte.com
(619) 393-1545
Media:
Tracy Morris
media@veracyte.com
(650) 380-4413
Source: Veracyte, Inc.
FAQ
When is Veracyte (VCYT) presenting at the UBS Healthcare Conference?
How long will Veracyte's (VCYT) conference webcasts be available for replay?
Which investor conferences is Veracyte (VCYT) attending in November?
Where can investors access Veracyte's (VCYT) conference presentations?
